These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36586521)

  • 81. Clinical and anti-inflammatory effects of treating endotoxin-challenged pigs with meloxicam.
    Friton GM; Schmidt H; Schrödl W
    Vet Rec; 2006 Oct; 159(17):552-7. PubMed ID: 17056651
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effects of cyclooxygenase inhibitors flunixin and deracoxib on permeability of ischaemic-injured equine jejunum.
    Tomlinson JE; Blikslager AT
    Equine Vet J; 2005 Jan; 37(1):75-80. PubMed ID: 15651739
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A comparative study of the effects of meloxicam and flunixin meglumine (NSAIDs) as adjunctive therapy on interferon and tumor necrosis factor production in calves suffering from enzootic bronchopneumonia.
    Bednarek D; Zdzisińska B; Kondracki M; Rzeski W; Paduch R; Kandefer-Szerszeń M
    Pol J Vet Sci; 2003; 6(2):109-15. PubMed ID: 12817781
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis.
    Morton AJ; Campbell NB; Gayle JM; Redding WR; Blikslager AT
    Res Vet Sci; 2005 Apr; 78(2):189-92. PubMed ID: 15563928
    [TBL] [Abstract][Full Text] [Related]  

  • 85. RAPID COMMUNICATION: TLR4 expressed but with reduced functionality on equine B lymphocytes.
    Hay AN; Potter A; Kasmark L; Zhu J; Leeth CM
    J Anim Sci; 2019 Apr; 97(5):2175-2180. PubMed ID: 30901382
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Nonsteroidal anti-inflammatory drugs affect the mammary epithelial barrier during inflammation.
    Sintes GF; Bruckmaier RM; Wellnitz O
    J Dairy Sci; 2020 Nov; 103(11):10742-10753. PubMed ID: 32896404
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Flunixin and its use in horses].
    Jaussaud P
    Ann Rech Vet; 1986; 17(4):353-62. PubMed ID: 3493724
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Comparison of the effects of IV administration of meloxicam, carprofen, and flunixin meglumine on prostaglandin E(2) concentration in aqueous humor of dogs with aqueocentesis-induced anterior uveitis.
    Gilmour MA; Payton ME
    Am J Vet Res; 2012 May; 73(5):698-703. PubMed ID: 22533402
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Update on the use of cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs in horses.
    Ziegler A; Fogle C; Blikslager A
    J Am Vet Med Assoc; 2017 Jun; 250(11):1271-1274. PubMed ID: 28509650
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effects of ischemia and the cyclooxygenase inhibitor flunixin on in vitro passage of lipopolysaccharide across equine jejunum.
    Tomlinson JE; Blikslager AT
    Am J Vet Res; 2004 Oct; 65(10):1377-83. PubMed ID: 15524324
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Development of an in Vivo Lipopolysaccharide Inflammation Model to Study the Pharmacodynamics of COX-2 Inhibitors Celecoxib, Mavacoxib, and Meloxicam in Cockatiels (
    Gasthuys E; Houben R; Haesendonck R; De Baere S; Sys SU; Morrens J; Antonissen G
    J Avian Med Surg; 2019 Dec; 33(4):349-360. PubMed ID: 31833303
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Short-term administration of flunixin meglumine or firocoxib does not alter viscoelastic coagulation profiles in healthy horses.
    Bishop RC; McCoy AM; Kemper AM; Stewart RM; Wilkins PA
    J Am Vet Med Assoc; 2022 Oct; 260(15):1963-1966. PubMed ID: 36198050
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effects of flunixin meglumine on short circuit current in equine colonic mucosa in vitro.
    Freeman DE; Inoue OJ; Eurell TE
    Am J Vet Res; 1997 Aug; 58(8):915-9. PubMed ID: 9256981
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pharmacokinetics of meloxicam after oral administration of a granule formulation to healthy horses.
    Mendoza FJ; Serrano-Rodriguez JM; Perez-Ecija A
    J Vet Intern Med; 2019 Mar; 33(2):961-967. PubMed ID: 30768821
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Duration of in vivo endotoxin tolerance in horses.
    Holcombe SJ; Jacobs CC; Cook VL; Gandy JC; Hauptman JG; Sordillo LM
    Vet Immunol Immunopathol; 2016 May; 173():10-6. PubMed ID: 27090620
    [TBL] [Abstract][Full Text] [Related]  

  • 96. In vivo priming and ex vivo activation of equine neutrophils in black walnut extract-induced equine laminitis is not attenuated by systemic lidocaine administration.
    Loftus JP; Williams JM; Belknap JK; Black SJ
    Vet Immunol Immunopathol; 2010 Nov; 138(1-2):60-9. PubMed ID: 20667603
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Comparative efficacy of oral meloxicam and phenylbutazone in 2 experimental pain models in the horse.
    ; Banse H; Cribb AE
    Can Vet J; 2017 Feb; 58(2):157-167. PubMed ID: 28216685
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effect of eltenac in horses with induced endotoxaemia.
    MacKay RJ; Daniels CA; Bleyaert HF; Bailey JE; Gillis KD; Merritt AM; Katz TL; Johnson JC; Thompson KC
    Equine Vet J Suppl; 2000 Jun; (32):26-31. PubMed ID: 11202378
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Nonsteroidal Anti-inflammatory Drug Use in Horses.
    Knych HK
    Vet Clin North Am Equine Pract; 2017 Apr; 33(1):1-15. PubMed ID: 28190614
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Determination of an effective dose of eltenac and its comparison with that of flunixin meglumine in horses after experimentally induced carpitis.
    Hamm D; Turchi P; Johnson JC; Lockwood PW; Thompson KC; Katz T
    Am J Vet Res; 1997 Mar; 58(3):298-302. PubMed ID: 9055978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.